This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (3)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Evidence-Based Medicine  • Neoplasms  • Dermatologic Surgery  • Alert me on articles by topic

Timothy M. Johnson, MD
Vernon K. Sondak, MD

Arch Dermatol. 2004;140:1148-1150.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Commentary on: Excision margins in high-risk malignant melanoma
Thomas JM, Newton-Bishop J, A'Hern R, et al, for the United Kingdom Melanoma Study Group, the British Association of Plastic Surgeons, and the Scottish Cancer Therapy Network
N Engl J Med. 2004;350:757-766.

Question: In patients with primary cutaneous melanoma 2 mm or thicker, is there a significant difference in recurrence and/or survival for excision with 1- vs 3-cm margins?
Design: Thomas and colleagues conducted a randomized clinical trial comparing 1vs 3-cm margins for melanoma 2 mm or thicker.
Setting: A multicenter trial was performed under the auspices of the United Kingdom Melanoma Study Group, the British Association of Plastic Surgeons, and the Scottish Cancer Therapy Network, coordinated by the Clinical Trials and Statistics Unit at the Institute of Cancer Research, Sutton, United Kingdom. Patients were recruited from January 1993 to July 2001.
Patients: Eligible . . . [Full Text of this Article]

Comment

University of Michigan Medical School, Ann Arbor

H. Lee Moffitt Cancer Center and Research Institute, Tampa Fla

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Markers and Tissue Resources for Melanoma: Meeting Report.
Becker et al.
Cancer Res. 2006;66:10652-10657.
ABSTRACT | FULL TEXT